The company said that the verdict, announced in May, "could have far-reaching consequences for the certainty and predictability of active substance approvals in the EU".
By appealing against the verdict, Bayer said it wants to ensure that some general interpretations of the crop protection law established by the court are re-considered. These interpretations may have importance beyond this particular case.
Bayer said it respects the European legislative process and accepts the recent decision of the EU Member States to broadly restrict the use of certain neonicotinoids in agriculture.
As a consequence, the company has withdrawn the clothianidin dossier from the ongoing renewal process.
Bayer said "there are other, better ways to support pollinator health – such as increasing pollinator foraging options or natural habitats and more efficient control of the varroa mite – than banning substances that have helped farmers effectively manage a broad range of significant pests."